CompletedNot Applicable

Stellate Ganglion Block in Bulbar Palsy

China124 participantsStarted 2024-03-23

Plain-language summary

This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in 3 hospitals in China. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, video fluoroscopic swallowing study, ultrasound diagnostic devices, and penetration-aspiration scale, Flexible laryngoscope are used to assess swallowing function.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with ischemic stroke according to the diagnostic criteria, with the stroke occurring in the medulla oblongata and diagnosed as bulbar palsy. * Age \>18 years. * First-time stroke. * Steady vital signs, * Transferred or admitted to the Department of Rehabilitation Medicine within 15-30d after onset. * No cognitive impairment or aphasia, with the Montreal Cognitive Assessment score ≥21 points. * No history of severe mental illness or psychotropic drug dependence. * Unsafe or insufficient oral intake, indicating the need for enteral feeding Exclusion Criteria: * Contraindications for Stellate Ganglion Block.. * Structural abnormalities of the oropharynx. * Complicated with other neurological diseases. * Tracheostomy tube inserted. * Simultaneously suffering from liver, kidney failure, tumors, or hematological diseases. * Dysphagia caused by other possible diseases. * Pregnant females.

What they're measuring

Modified Barium Swallow Impairment Profile

Timeframe: day 1 before any intervention, day 11, and day 60

Trial details

NCT IDNCT06319534

SponsorZeng Xi

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2025-06-05